12 results
6-K
EX-99.1
GMVDF
G Medical Innovations Holdings Ltd.
7 Aug 23
G Medical Innovations’ CEO Issues Update to Shareholders, August 2023
4:23pm
in healthcare leadership for large healthcare organizations across the US. He brings extensive experience in business development, strategic
6-K
EX-99.1
GMVDF
G Medical Innovations Holdings Ltd.
18 Apr 23
Report of Foreign Private Issuer
4:15pm
conviction in the continued growth of G Medical. “I firmly believe that G Medical’s continued growth evidences its leadership in providing wholistic … 48 hours of mailing the sample to its lab; the continued growth of G Medical; and that its continued growth evidences its leadership in providing
424B4
GMVDF
G Medical Innovations Holdings Ltd.
4 Apr 23
Prospectus supplement with pricing info
12:13pm
in financial leadership positions in the e-commerce, biotechnology, petrochemical, and medical cannabis industries. From 2020 through 2022, Mr. Bluvstein served
6-K
GMVDF
G Medical Innovations Holdings Ltd.
7 Jul 22
Report of Foreign Private Issuer
4:52pm
) years of experience working in financial leadership positions in the e-commerce, biotechnology, petrochemical, and medical cannabis industries. From 2020
20-F
xwxc lt9dna
29 Apr 22
Annual report (foreign)
12:00am
F-1
EX-10.35
s2ada5m2w51 h19z
4 Mar 21
Registration statement (foreign)
12:00am
DRS/A
EX-10.32
wb4bczi
23 Feb 21
Draft registration statement (amended)
12:00am
F-1
EX-10.15
1zkc7ck6xm uo
1 Oct 20
Registration statement (foreign)
12:00am
DRS
EX-10.15
lvqcz9cx28iylwtulaf
17 Jul 20
Draft registration statement
12:00am
F-1/A
EX-10.15
n4vocxbqma3o2yrqyy0
3 Jun 19
Registration statement (foreign) (amended)
7:52am
F-1
EX-10.15
4zn6hb
17 May 19
Registration statement (foreign)
5:28pm
- Prev
- 1
- Next